CIK: 1742766 - Address: 300 Technology Square, 8Th Floor, Cambridge, MA 02139
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/29/21 19:15
9/27/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS.m-2,06025.400-81-18,279M
9/24/21 20:59
9/22/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS.m-3,51226.020-135-28,361M
8/12/21 10:42
8/11/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Associates X, L.P.MATS-14,77061.000-242-45,763D
6/28/21 16:56
6/24/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS-80225.850-31-981M
6/23/21 20:26
6/21/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS.m-4,63625.050-185-8532M
4/14/21 20:19
4/12/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS.m-3,64725.920-141-29,112D
4/9/21 20:54
4/7/21
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsAtlas Venture Associates X, L.P.MATS.m-3,58428.200-127-19,253D
3/16/21 19:37
3/12/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Associates X, L.P.MATS-12,95856.500-229-36,886D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact